The African Medical Centre of Excellence (AMCE) officially opened today, marking a historic milestone in Africa's journey ...

The trial is evaluating EB103, which is a CD19-redirected ARTEMIS® T-cell therapy, in adult patients (aged 18 and older) with ...

A guide to the recommended hours of sleep for women and the factors that effect their ability to get quality rest ...

The analysts are supporting the company’s potential in the broader mental health sector, demonstrating the transformative ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...

There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...

Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...